Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Arturo Alvarez-Buylla
University of California, San Francisco, Department: Neurosurgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Neurona Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
An Interneuron-based Cell Therapy for Epilepsy
Epilepsy is a common neurological disorder afflicting nearly 3 million Americans. Given that loss or reduction of inhibitory synaptic transmission in hippocampus is one potential mechanism resulting in the emergence of epilepsy, a method to generate new hippocampal interneurons could have direct therapeutic consequences. Using mouse embryonic neural progenitor cells and a rodent model of epilepsy we propose to better understand and develop a novel interneuron-based cell therapy.
Filed on July 17, 2015.
Tell us what you know about Arturo Alvarez-Buylla's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Arturo Alvarez-Buylla”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Arturo Alvarez-Buylla | University of California, San Francisco | Conflict of Interest | Neurona Therapeutics | $0 - $4,999 |
| Arturo Alvarez-Buylla | University of California, San Francisco | Conflict of Interest | Neurona Therapeutics | $40,000 - $59,999 |
| Arturo Alvarez-Buylla | University of California, San Francisco | Conflict of Interest | Neurona Therapeutics | $80,000 - $99,999 |
| Arturo Alvarez-Buylla | University of California, San Francisco | Conflict of Interest | Neurona Therapeutics | $80,000 - $99,999 |
| Arturo Alvarez-Buylla | University of California, San Francisco | Conflict of Interest | Neurona Therapeutics | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.